NYMC Faculty Publications

Sexual and Fertility Adverse Effects Associated With Chemotherapy Treatment in Women

Author Type(s)

Faculty

DOI

10.1517/14740338.2014.915940

Journal Title

Expert Opinion on Drug Safety

First Page

775

Last Page

783

Document Type

Article

Publication Date

6-1-2014

Department

Obstetrics and Gynecology

Keywords

Animals, Antineoplastic Agents, Female, Humans, Infertility, Female, Neoplasms, Primary Ovarian Insufficiency, Quality of Life, Risk Factors, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

Disciplines

Medicine and Health Sciences

Abstract

INTRODUCTION: Earlier diagnosis and novel chemotherapy strategies have resulted in a considerable improvement in cancer survival, but the quality of that survival is influenced by late effects of chemotherapy. Premature ovarian failure is a common consequence of chemotherapy in reproductive-aged women, and, as a result, fertility issues and sexual dysfunction occur frequently in women who have undergone chemotherapy.

AREAS COVERED: This article reviews what is known about the effects of chemotherapy on fertility and sexuality. We also discuss risk factors for premature ovarian failure, fertility preservation options in patients willing to have a child after treatment, and sexual changes associated with estrogen withdrawal and psychological factors.

EXPERT OPINION: Chemotherapy-induced ovarian failure in young women is associated with poorer quality of life, decreased sexual functioning, psychosocial distress related to fertility concerns, and infertility. Fertility preservation options should be considered in women at risk of premature ovarian failure caused by chemotherapy. Sexual dysfunction associated with estrogen withdrawal and psychological stress is common in cancer survivors. Women who suffer from sexual dysfunction may benefit from brief counseling and targeted intervention.

Link to Full Text

Share

COinS